Psilocybin for Major Depressive Disorder (MDD)

Clinical trial NCT06308653 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06308653
Sponsor: Usona Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2024-03-13
Primary completion: 2026-01-05
Enrollment: 238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.